FIELD: medicine.
SUBSTANCE: method involves modeling acute brain ischemia in animal by means of unilateral extravasal occlusion of common carotid artery. Gamma-interferon is intraperitoneally introduced to mammalian at a dose of 5000 MU/kg of body mass once a day during 3 days before common carotid artery occlusion.
EFFECT: enhanced effectiveness of prophylaxis.
1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
| METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| METHOD FOR PREVENTION OF BRAIN ISCHEMIA | 2017 |
|
RU2642961C1 |
| METHOD FOR CEREBRAL PROTECTION IN RECONSTRUCTIVE SURGERY OF CAROTID ARTERIES | 2004 |
|
RU2279878C2 |
